Healthcare Journal of Oregon: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.

Press releases published on October 12, 2026

13 hours ago

Academy for Sports Dentistry and EA4SD Issue Joint Consensus Statement Defining the Qualified Sports Dentist

Indeterminate EIN Presswire

5 hours ago

NexLife Announces October 2026 GLP-1 Price Index on Online Prices of Compounded Tirzepatide and Semaglutide

Indeterminate GlobeNewswire

5 hours ago

Teva to Host R&D Day on Wednesday, November 11 in New York City

Indeterminate GlobeNewswire

6 hours ago

LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026

Indeterminate GlobeNewswire

7 hours ago

Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor Agonist

Indeterminate GlobeNewswire

7 hours ago

Broken Tooth in West Hollywood? Same-Day Extraction and Implant Placement May Be an Option for Qualifying Patients

Indeterminate GlobeNewswire

7 hours ago

TeleSpecialists Reaches 2 Million Patient Encounters, Achieving Second Million in Less Than One-Third the Time

Indeterminate GlobeNewswire

7 hours ago

Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers

Indeterminate GlobeNewswire

7 hours ago

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

7 hours ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

7 hours ago

Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026

Indeterminate GlobeNewswire

7 hours ago

PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026

Indeterminate GlobeNewswire

7 hours ago

Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

7 hours ago

ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results

Indeterminate GlobeNewswire

7 hours ago

Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series

Indeterminate GlobeNewswire

7 hours ago

Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update

Indeterminate GlobeNewswire

7 hours ago

ArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002

Indeterminate GlobeNewswire

7 hours ago

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

Indeterminate GlobeNewswire

7 hours ago

Syndax Announces Topline Results from MAXPIRe Phase 2 Trial of Axatilimab in Idiopathic Pulmonary Fibrosis

Indeterminate GlobeNewswire

7 hours ago

Cytokinetics Announces Additional Data from ACACIA-HCM Presented at the HFSA Annual Scientific Meeting 2026

Indeterminate GlobeNewswire